More articles from Interstitial lung disease

Indications and patterns of use of benzodiazepines and opioids in severe interstitial lung disease: a population-based longitudinal study
Jenny Genberg, Joanna M. Davies, Zainab Ahmadi, David Currow, Miriam J. Johnson, Hanan Tanash, Sabrina Bajwah, Magnus Ekström

ERJ Open Research Jan 2021, 7 (1) 00716-2020; DOI: 10.1183/23120541.00716-2020
Idiopathic pulmonary fibrosis in the UK: analysis of the British Thoracic Society electronic registry between 2013 and 2019
Lisa G. Spencer, Maria Loughenbury, Nazia Chaudhuri, Monica Spiteri, Helen Parfrey

ERJ Open Research Jan 2021, 7 (1) 00187-2020; DOI: 10.1183/23120541.00187-2020
Pharmacological and nonpharmacological interventions to improve symptom control, functional exercise capacity and quality of life in interstitial lung disease: an evidence synthesis
Sabrina Bajwah, Jill Colquitt, Emma Loveman, Claudia Bausewein, Howard Almond, Adejoke Oluyase, Mendy Dzingina, Matthew Maddocks, Irene J. Higginson, Athol Wells

ERJ Open Research Jan 2021, 7 (1) 00107-2020; DOI: 10.1183/23120541.00107-2020
Oscillometry and computed tomography findings in patients with idiopathic pulmonary fibrosis
Yuji Yamamoto, Keisuke Miki, Kazuyuki Tsujino, Tomoki Kuge, Fukuko Okabe, Takahiro Kawasaki, Takanori Matsuki, Hiroyuki Kagawa, Mari Miki, Hiroshi Kida

ERJ Open Research Oct 2020, 6 (4) 00391-2020; DOI: 10.1183/23120541.00391-2020
Dynamics in diagnoses and pharmacotherapy before and after diagnosing idiopathic pulmonary fibrosis
Jesper Rømhild Davidsen, Lars Christian Lund, Christian B. Laursen, Jesper Hallas, Daniel Pilsgaard Henriksen

ERJ Open Research Oct 2020, 6 (4) 00479-2020; DOI: 10.1183/23120541.00479-2020
Azithromycin for sarcoidosis cough: an open-label exploratory clinical trial
Simon D. Fraser, Susannah Thackray-Nocera, Marica Shepherd, Rachel Flockton, Caroline Wright, Wayne Sheedy, Kayleigh Brindle, Alyn H. Morice, Paul M. Kaye, Michael G. Crooks, Simon P. Hart

ERJ Open Research Oct 2020, 6 (4) 00534-2020; DOI: 10.1183/23120541.00534-2020
Circulating fibrocytes as prognostic biomarkers of autoimmune interstitial lung disease
John Odackal, Victor Yu, Diana Gomez-Manjerres, Joshua J. Field, Marie D. Burdick, Borna Mehrad

ERJ Open Research Oct 2020, 6 (4) 00481-2020; DOI: 10.1183/23120541.00481-2020
Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study
Vasilios Tzilas, Argyris Tzouvelekis, Evangelos Bouros, Theodoros Karampitsakos, Maria Ntassiou, Eleni Avdoula, Athena Trachalaki, Katerina Antoniou, Ganesh Raghu, Demosthenes Bouros

ERJ Open Research Oct 2020, 6 (4) 00152-2020; DOI: 10.1183/23120541.00152-2020
Factor analysis identifies three separate symptom clusters in idiopathic pulmonary fibrosis
Severi Seppälä, Kaisa Rajala, Juho Tuomas Lehto, Eva Sutinen, Laura Mäkitalo, Hannu Kautiainen, Hannu Kankaanranta, Mari Ainola, Tiina Saarto, Marjukka Myllärniemi

ERJ Open Research Oct 2020, 6 (4) 00347-2020; DOI: 10.1183/23120541.00347-2020
Clinical predictors and explant lung pathology of acute exacerbation of idiopathic pulmonary fibrosis
Yaniv Dotan, William B. Shapiro, Eneida Male, Eduardo C. Dominguez, Amandeep Aneja, Zhao Huaqing, Chandra Dass, Kartik Shenoy, Nathaniel Marchetti, Francis C. Cordova, Gerard J. Criner, A. James Mamary

ERJ Open Research Oct 2020, 6 (4) 00261-2019; DOI: 10.1183/23120541.00261-2019

Main menu

User menu

Search

More articles from Interstitial lung disease

Pages

Contact us